Literature DB >> 16741322

Colony stimulating factors as adjunctive therapy in neonatal sepsis.

Geeta Gathwala, Harsh Bala.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16741322     DOI： 10.1007/bf02758558

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN： 0019-5456            Impact factor:   1.967


× No keyword cloud information.
  15 in total

1.  A trial of recombinant human granulocyte colony stimulating factor for the treatment of very low birthweight infants with presumed sepsis and neutropenia.

Authors:  A R Bedford Russell; A J Emmerson; N Wilkinson; T Chant; D G Sweet; H L Halliday; B Holland; E G Davies
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2001-05       Impact factor: 5.747

2.  Human granulocyte colony-stimulating factor may improve outcome attributable to neonatal sepsis complicated by neutropenia.

Authors:  P Kocherlakota; E F La Gamma
Journal:  Pediatrics       Date:  1997-07       Impact factor: 7.124

3.  A randomized trial of granulocyte-macrophage colony-stimulating factor in neonates with sepsis and neutropenia.

Authors:  K Bilgin; A Yaramiş; K Haspolat; M A Taş; S Günbey; O Derman
Journal:  Pediatrics       Date:  2001-01       Impact factor: 7.124

4.  Administration of recombinant granulocyte colony-stimulating factor to neonates with septicemia: A meta-analysis.

Authors:  H M Bernstein; B H Pollock; D A Calhoun; R D Christensen
Journal:  J Pediatr       Date:  2001-06       Impact factor: 4.406

5.  Hematologic scoring system in early diagnosis of sepsis in neutropenic newborns.

Authors:  R L Rodwell; K M Taylor; D I Tudehope; P H Gray
Journal:  Pediatr Infect Dis J       Date:  1993-05       Impact factor: 2.129

6.  Production of granulocyte colony-stimulating factor in vitro by monocytes from preterm and term neonates.

Authors:  K R Schibler; K W Liechty; W L White; R D Christensen
Journal:  Blood       Date:  1993-10-15       Impact factor: 22.113

7.  Administration of recombinant human granulocyte-colony stimulating factor to septic neonates induces neutrophilia and enhances the neutrophil respiratory burst and beta2 integrin expression. Results of a randomized controlled trial.

Authors:  V Drossou-Agakidou; F Kanakoudi-Tsakalidou; K Sarafidis; A Taparkou; V Tzimouli; H Tsandali; G Kremenopoulos
Journal:  Eur J Pediatr       Date:  1998-07       Impact factor: 3.183

8.  Comparison of recombinant granulocyte colony-stimulating factor, recombinant human granulocyte-macrophage colony-stimulating factor and placebo for treatment of septic preterm infants.

Authors:  Asma Ahmad; Gary Laborada; James Bussel; Mirjana Nesin
Journal:  Pediatr Infect Dis J       Date:  2002-11       Impact factor: 2.129

9.  A two-year follow-up of neonates with presumed sepsis treated with recombinant human granulocyte colony-stimulating factor during the first week of life.

Authors:  J Rosenthal; T Healey; R Ellis; E Gillan; M S Cairo
Journal:  J Pediatr       Date:  1996-01       Impact factor: 4.406

10.  A randomized, placebo-controlled trial of recombinant human granulocyte colony-stimulating factor administration in newborn infants with presumed sepsis: significant induction of peripheral and bone marrow neutrophilia.

Authors:  E R Gillan; R D Christensen; Y Suen; R Ellis; C van de Ven; M S Cairo
Journal:  Blood       Date:  1994-09-01       Impact factor: 22.113
View more
  1 in total

1.  The effect of granulocyte colony stimulating factor administration on preterm infant with neutropenia and clinical sepsis: a randomized clinical trial.

Authors:  L Borjianyazdi; M Froomandi; M Noori Shadkam; A Hashemi; R Fallah
Journal:  Iran J Ped Hematol Oncol       Date:  2013-04-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.